Alerts will be sent to your verified email
Verify Email
FDC
|
FDC
|
Strides Pharma Scien
|
Procter&Gamble Healt
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
5.1 % | n/a | 20.1 % |
|
R&D as a % of Total Sales
|
2.06 % | 1.82 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
13.66 % | -4.18 % | 30.46 % |
|
5yr average Equity Multiplier
|
1.57 | 2.64 | 2.99 |
|
5yr Average Asset Turnover Ratio
|
0.54 | 0.54 | 0.57 |
|
5yr Avg Net Profit Margin
|
16.24 % | -2.56 % | 17.93 % |
|
Price to Book
|
3.11 | 2.86 | 17.33 |
|
P/E
|
26.59 | 2.03 | 37.04 |
|
5yr Avg Cash Conversion Cycle
|
-14.0 Days | -66.38 Days | -158.56 Days |
|
Inventory Days
|
59.23 Days | 69.16 Days | 36.98 Days |
|
Days Receivable
|
21.91 Days | 71.28 Days | 29.14 Days |
|
Days Payable
|
86.54 Days | 248.23 Days | 177.2 Days |
|
5yr Average Interest Coverage Ratio
|
93.3 | 0.41 | 337.3 |
|
5yr Avg ROCE
|
14.95 % | 9.77 % | 19.93 % |
|
5yr Avg Operating Profit Margin
|
18.97 % | 13.1 % | 24.91 % |
|
5 yr average Debt to Equity
|
0.0 | 1.02 | 0.0 |
|
5yr CAGR Net Profit
|
4.94 % | n/a | -4.58 % |
|
5yr Average Return on Assets
|
8.73 % | -1.34 % | 10.24 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.66 % | 28.3 % | 51.82 % |
|
Share Pledged by Promoters
|
0.0 | 51.98 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.3 % | -2.3 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.49 % | -3.5 % | 4.1 % |